Cargando…

IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo

BACKGROUND: Myeloid cells, such as macrophages and microglia, play a crucial role in neuroinflammation and have been recently identified as a novel therapeutic target, especially for chronic forms. The general aim would be to change the phenotype of myeloid cells from pro- to anti-inflammatory, favo...

Descripción completa

Detalles Bibliográficos
Autores principales: Casella, Giacomo, Garzetti, Livia, Gatta, Alberto T., Finardi, Annamaria, Maiorino, Chiara, Ruffini, Francesca, Martino, Gianvito, Muzio, Luca, Furlan, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895901/
https://www.ncbi.nlm.nih.gov/pubmed/27266518
http://dx.doi.org/10.1186/s12974-016-0596-5
_version_ 1782435946663247872
author Casella, Giacomo
Garzetti, Livia
Gatta, Alberto T.
Finardi, Annamaria
Maiorino, Chiara
Ruffini, Francesca
Martino, Gianvito
Muzio, Luca
Furlan, Roberto
author_facet Casella, Giacomo
Garzetti, Livia
Gatta, Alberto T.
Finardi, Annamaria
Maiorino, Chiara
Ruffini, Francesca
Martino, Gianvito
Muzio, Luca
Furlan, Roberto
author_sort Casella, Giacomo
collection PubMed
description BACKGROUND: Myeloid cells, such as macrophages and microglia, play a crucial role in neuroinflammation and have been recently identified as a novel therapeutic target, especially for chronic forms. The general aim would be to change the phenotype of myeloid cells from pro- to anti-inflammatory, favoring their tissue-trophic and regenerative functions. Myeloid cells, however, display a number of functional phenotypes, not immediately identifiable as pro- or anti-inflammatory, and associated to ambiguous markers. METHODS: We employed in vitro assays to study macrophage polarization/differentiation in the presence of classical polarizing stimuli such as IFNγ (pro-inflammatory) and IL4 (anti-inflammatory). We induced neuroinflammation in mice by immunization with a myelin antigen and treated diseased mice with intracisternal delivery of an IL4-expressing lentiviral vector. We analyzed clinical, pathological, and immunological outcomes with a focus on myeloid cells. RESULTS: We found that IL6, usually considered a pro-inflammatory cytokine, was released in vitro by macrophages treated with the anti-inflammatory cytokine IL4. We show the existence of macrophages expressing IL6 along with classical anti-inflammatory markers such as CD206 and demonstrate that these cells are immunosuppressive in vitro. In neuroinflamed mice, we show that IL4 delivery in the central nervous system (CNS) is associated with clinical and pathological protection from disease, associated with increased IL6 expression in infiltrating macrophages. CONCLUSIONS: IL6 is known to mediate both pro- and anti-inflammatory effects, having two distinct ways to induce cell-signaling: either through the membrane bound receptor (anti-inflammatory) or through trans-signaling (pro-inflammatory). We show here that IL6-expressing macrophages are associated to protection from neuroinflammation, suggesting that IL6 anti-inflammatory properties prevail in the CNS, and calling for a general reconsideration of IL6 in macrophage polarization. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0596-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4895901
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48959012016-06-08 IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo Casella, Giacomo Garzetti, Livia Gatta, Alberto T. Finardi, Annamaria Maiorino, Chiara Ruffini, Francesca Martino, Gianvito Muzio, Luca Furlan, Roberto J Neuroinflammation Research BACKGROUND: Myeloid cells, such as macrophages and microglia, play a crucial role in neuroinflammation and have been recently identified as a novel therapeutic target, especially for chronic forms. The general aim would be to change the phenotype of myeloid cells from pro- to anti-inflammatory, favoring their tissue-trophic and regenerative functions. Myeloid cells, however, display a number of functional phenotypes, not immediately identifiable as pro- or anti-inflammatory, and associated to ambiguous markers. METHODS: We employed in vitro assays to study macrophage polarization/differentiation in the presence of classical polarizing stimuli such as IFNγ (pro-inflammatory) and IL4 (anti-inflammatory). We induced neuroinflammation in mice by immunization with a myelin antigen and treated diseased mice with intracisternal delivery of an IL4-expressing lentiviral vector. We analyzed clinical, pathological, and immunological outcomes with a focus on myeloid cells. RESULTS: We found that IL6, usually considered a pro-inflammatory cytokine, was released in vitro by macrophages treated with the anti-inflammatory cytokine IL4. We show the existence of macrophages expressing IL6 along with classical anti-inflammatory markers such as CD206 and demonstrate that these cells are immunosuppressive in vitro. In neuroinflamed mice, we show that IL4 delivery in the central nervous system (CNS) is associated with clinical and pathological protection from disease, associated with increased IL6 expression in infiltrating macrophages. CONCLUSIONS: IL6 is known to mediate both pro- and anti-inflammatory effects, having two distinct ways to induce cell-signaling: either through the membrane bound receptor (anti-inflammatory) or through trans-signaling (pro-inflammatory). We show here that IL6-expressing macrophages are associated to protection from neuroinflammation, suggesting that IL6 anti-inflammatory properties prevail in the CNS, and calling for a general reconsideration of IL6 in macrophage polarization. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0596-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-07 /pmc/articles/PMC4895901/ /pubmed/27266518 http://dx.doi.org/10.1186/s12974-016-0596-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Casella, Giacomo
Garzetti, Livia
Gatta, Alberto T.
Finardi, Annamaria
Maiorino, Chiara
Ruffini, Francesca
Martino, Gianvito
Muzio, Luca
Furlan, Roberto
IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
title IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
title_full IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
title_fullStr IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
title_full_unstemmed IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
title_short IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
title_sort il4 induces il6-producing m2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895901/
https://www.ncbi.nlm.nih.gov/pubmed/27266518
http://dx.doi.org/10.1186/s12974-016-0596-5
work_keys_str_mv AT casellagiacomo il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT garzettilivia il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT gattaalbertot il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT finardiannamaria il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT maiorinochiara il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT ruffinifrancesca il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT martinogianvito il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT muzioluca il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo
AT furlanroberto il4inducesil6producingm2macrophagesassociatedtoinhibitionofneuroinflammationinvitroandinvivo